Lew J, Sheeder J, Lazorwitz A. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients. Contraception. 2021 Nov;104(5):556-560. PubMed PMID: 34147509
Lazorwitz A, Teal S. Using pharmacologic research to efficiently meet acute contraceptive needs. Fertil Steril. 2021 Apr;115(4):903-904. PubMed PMID: 33832748
Lazorwitz A, Aquilante CL, Shortt JA, Sheeder J, Teal S, Gignoux CR. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception. Clin Transl Sci. 2021 Sep;14(5):1713-1718. PubMed PMID: 33650294
Lazorwitz A, Sheeder J, Teal S. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users. Eur J Contracept Reprod Health Care. 2021 Aug;26(4):323-325. PubMed PMID: 33596152
Lazorwitz A, Dindinger E, Harrison M, Aquilante CL, Sheeder J, Teal S. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users. Contraception. 2020 Sep;102(3):180-185. PubMed PMID: 32407811
Lazorwitz A, Seale R, Davis A, Guiahi M. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users. Contraception. 2020 Jul;102(1):58-60. PubMed PMID: 32325076
Fang NZ, Guiahi M, Lazorwitz A. Satisfaction with medication abortion and marijuana use: A prospective cohort study. Contraception. 2020 Jul;102(1):30-33. PubMed PMID: 32278684
Lazorwitz A, Aquilante CL, Sheeder J, Teal S. Letter to the Editor in Response to "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally". Adv Ther. 2020 Feb;37(2):963-964. PubMed PMID: 31875298
Lazorwitz A, Dindinger E, Aguirre N, Sheeder J. Pre- and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital. J Anesth. 2020 Apr;34(2):294-297. PubMed PMID: 31865457
Lazorwitz A, Aquilante CL, Sheeder J, Guiahi M, Teal S. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users. Contraception. 2019 Jul;100(1):37-41. PubMed PMID: 30980827
Lazorwitz A, Aquilante CL, Dindinger E, Harrison M, Sheeder J, Teal S. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. Obstet Gynecol. 2019 Oct;134(4):807-813. PubMed PMID: 31503152
Lazorwitz A, Aquilante CL, Oreschak K, Sheeder J, Guiahi M, Teal S. Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users. Obstet Gynecol. 2019 Apr;133(4):783-794. PubMed PMID: 30870275
Lazorwitz A, Aquilante CL, Sheeder J, Teal S. Letter to the Editor in Response to "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally". Adv Ther. 2019 Dec 24. [Epub ahead of print] PubMed PMID: 31875298
Lazorwitz A, Dindinger E, Aguirre N, Sheeder J. Pre- and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital. J Anesth. 2019 Dec 21. [Epub ahead of print] PubMed PMID: 31865457
Lazorwitz A, Coleman-Minahan K, Teal SB, Guiahi M. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy. J Adolesc Health. 2018 Sep;63(3):363-364. PubMed PMID: 30076014
Lazorwitz A, Sheeder J, Teal S. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period. Contraception 2021; in press.
Lazorwitz A, Pena M, Sheeder J, Teal S. Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users. Obstetrics & Gynecology 2021; in press.